Get the Stockscreener App
4.7723
0.22%
0.2423
Endra Life Sciences Inc stock is traded at $4.7723, with a volume of 658.
It is up +0.22% in the last 24 hours and down -23.83% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$4.53
Open:
$4.54
24h Volume:
658
Relative Volume:
0.00
Market Cap:
$5.30M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.0069
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
-4.62%
1M Performance:
-23.83%
6M Performance:
+28.25%
1Y Performance:
-29.88%
1-Day Range:
$4.54
$4.54
1-Week Range:
$4.19
$4.65
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
4.54 | 5.28M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
620.86 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
237.80 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.87 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.90 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
238.00 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Endra Life Sciences Inc Stock (NDRA) Latest News
$5 Stocks Gaining Attention for 2026: EKSO, NDRA, ONTF, FLYE, RDZN See Why Inside - openPR.com
ENDRA Life Sciences Inc.Common Stock (Nasdaq:NDRA) Stock Quote - FinancialContent
Why ENDRA Life Sciences Inc. stock is favored by pension fundsMarket Risk Analysis & High Accuracy Trade Alerts - Улправда
What technical charts say about ENDRA Life Sciences Inc. stock2025 Investor Takeaways & Community Shared Stock Ideas - Улправда
Why ENDRA Life Sciences Inc. stock attracts high net worth investorsMarket Movers & Daily Chart Pattern Signals - DonanımHaber
Quarterly Risk: What technical charts say about ENDRA Life Sciences Inc. stockOptions Play & Long-Term Growth Portfolio Plans - Улправда
Can ENDRA Life Sciences Inc. stock attract ESG capital inflowsJuly 2025 Volume & Low Risk High Reward Ideas - Улправда
What hedge fund activity signals for ENDRA Life Sciences Inc. stockJuly 2025 Trends & Consistent Profit Trading Strategies - Улправда
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy - Barchart.com
Endra Life Sciences shareholders approve share increase and board elections - Investing.com
Top Premarket Decliners - marketscreener.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
ENDRA Life Sciences (Nasdaq: NDRA) shareholders back 1,000,000,000-share increase - Stock Titan
A Look at ENDRA Life Sciences Inc (NDRA) Shares in the Recent Past Indicates Growth - setenews.com
ENDRA Life Sciences (NASDAQ:NDRA) Price Target Lowered to $30.00 at Ascendiant Capital Markets - Defense World
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS Registered - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active - Barchart.com
Aug Rallies: How geopolitical tensions affect ENDRA Life Sciences Inc stockProfit Target & Weekly High Return Stock Forecasts - moha.gov.vn
Ascendiant Capital Maintains ENDRA Life Sciences (NDRA) Buy Recommendation - Nasdaq
ENDRA Life Sciences (NDRA) Receives Adjusted Price Target with B - GuruFocus
Endra Life Sciences announces results from Taeus liver device feasibility study - MSN
ENDRA’s liver fat measurement device shows high accuracy at key thresholds - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
ENDRA Life Sciences (NDRA) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat
Endra Life Sciences (NDRA) Announces Promising Results from Live - GuruFocus
ENDRA Life Sciences stock falls after liver device study results By Investing.com - Investing.com Canada
Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use - Business Wire
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use - Yahoo Finance
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform - marketscreener.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS Registered Liver Imaging Platform - openPR.com
ENDRA Life Sciences Inc. (NDRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Jobs Data: What technical charts say about ENDRA Life Sciences Inc. stock2025 Short Interest & Step-by-Step Swing Trade Plans - BỘ NỘI VỤ
ENDRA Life Sciences Announces Management Changes - TradingView — Track All Markets
ENDRA Life Sciences Inc. Announces Resignation of Michael Thornton as Chief Technology Officer, Effective November 28, 2025 - marketscreener.com
What analysts say about ENDRA Life Sciences Inc stockBlue Chip Stock Analysis & Free Trading Psychology Coaching - earlytimes.in
You might want to take a look at ENDRA Life Sciences Inc (NDRA) now - Setenews
NDRA registers 2.68M-share resale, pivots to HYPE crypto strategy - Stock Titan
Form DEF 14AOther definitive proxy statements - ADVFN
Form 8-KCurrent report - ADVFN
ENDRA Life Sciences (NASDAQ: NDRA) Advances - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology - Barchart.com
ENDRA Life Sciences (NASDAQ:NDRA) Rating Increased to Sell at Wall Street Zen - Defense World
How Market Conditions Affect Cigniti Technologies Limiteds Growth StrategyHigh Beta Stocks & Double Digit Capital Growth - earlytimes.in
How strong is ENDRA Life Sciences Inc. stock revenue growth2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker - BioSpace
ENDRA’s liver fat measurement device shows strong correlation with MRI By Investing.com - Investing.com Nigeria
ENDRA Life Sciences Inc. (NDRA) -21.7% in Normal Trading: Significant Drop Amid Recent Study Announcement - Stocks Telegraph
ENDRA’s liver fat measurement device shows strong correlation with MRI - Investing.com
How ENDRA Life Sciences Inc. stock performs during Fed tightening cyclesJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Can ENDRA Life Sciences Inc. rally from current levels2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):